Sayas, C. Laura

GSK-3 and tau: a key duet in Alzheimer’s disease

Sayas, C. L., & Ávila, J. (2021) · Cells

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 314

Tau Structures

Avila, J., Jiménez, J. S., Sayas, C. L., Bolós, M., Zabala, J. C., Rivas, G., & Hernández, F. (2016) · Frontiers in Aging Neuroscience

Alzheimer's disease research and treatmentsProtein Structure and Dynamics

Cited by 140

GSK-3 Is Activated by the Tyrosine Kinase Pyk2 during LPA1-mediated Neurite Retraction

Sayas, C. L., Ariaens, A., Ponsioen, B., & Moolenaar, W. H. (2006) · Molecular Biology of the Cell

Protein Kinase Regulation and GTPase SignalingSphingolipid Metabolism and Signaling

Cited by 115

Discovery of autism/intellectual disability somatic mutations in Alzheimer’s brains: mutated ADNP cytoskeletal impairments and repair as a case study

Ivashko-Pachima, Y., Hadar, A., Grigg, I., Korenková, V., Kapitansky, O., Karmon, G., Gershovits, M., Sayas, C. L., Kooy, R. F., Attems, J., et al. (2021) · Molecular Psychiatry

Alzheimer's disease research and treatmentsGenetics and Neurodevelopmental Disorders

Cited by 107